39 results
Page 2 of 2
S-3
5r6zo
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.9
8txi9d2ok6q9g
5 Aug 22
Shelf registration
5:08pm
S-3
EX-1.2
xlgu9zve5yiosivc9l
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.8
8d3iquk5yo
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
bvy43uy2ss59 t2x
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
p71qz5
29 Mar 22
Annual report
8:46am
10-K
EX-10.11
5nzjncu
29 Mar 22
Annual report
8:46am
10-Q
89i1s4rzm5f
8 Sep 21
Quarterly report
8:37am
424B4
lwfail
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
50opj2i
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.10
ezggqm bhp4t1j31
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
2qqin9d vy97u2348
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-10.10
is01u4l iyzkm
25 Jun 21
IPO registration
5:28pm
S-1
6wklavifewvjml4x
25 Jun 21
IPO registration
5:28pm
DRS/A
cmekfunadrl87s
31 Mar 21
Draft registration statement (amended)
12:00am